BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen C, Gao FH. Th17 Cells Paradoxical Roles in Melanoma and Potential Application in Immunotherapy. Front Immunol 2019;10:187. [PMID: 30800130 DOI: 10.3389/fimmu.2019.00187] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Gupta M, Wahi A, Sharma P, Nagpal R, Raina N, Kaurav M, Bhattacharya J, Rodrigues Oliveira SM, Dolma KG, Paul AK, de Lourdes Pereira M, Wilairatana P, Rahmatullah M, Nissapatorn V. Recent Advances in Cancer Vaccines: Challenges, Achievements, and Futuristic Prospects. Vaccines 2022;10:2011. [DOI: 10.3390/vaccines10122011] [Reference Citation Analysis]
2 Iwamuro M, Takahashi T, Hirabata A, Tanaka T, Otsuka F, Okada H. Increased CCR4+ and Decreased Central Memory CD4+ T Lymphocytes in the Background Gastric Mucosa of Patients Developing Gastric Cancer After Helicobacter pylori Eradication: An Exploratory Study. Cureus 2022. [DOI: 10.7759/cureus.31713] [Reference Citation Analysis]
3 Yang X, Wang X, Sun X, Xiao M, Fan L, Su Y, Xue L, Luo S, Hou S, Wang H. Construction of five cuproptosis-related lncRNA signature for predicting prognosis and immune activity in skin cutaneous melanoma. Front Genet 2022;13:972899. [DOI: 10.3389/fgene.2022.972899] [Reference Citation Analysis]
4 Jin K, Li T, Miao Z, Ran J, Chen L, Mou D, Wang C, Wu S, Yang H, Fu X. Stat5−/− CD4+ T cells elicit anti-melanoma effect by CD4+ T cell remolding and Notch1 activation. Sci China Life Sci 2022;65:1824-1839. [DOI: 10.1007/s11427-021-2078-6] [Reference Citation Analysis]
5 D. Radosavljevic G, Pantic J, Simovic Markovic B, Arsenijevic N. Modulators of Tumor Angiogenesis: Insights into the Role of Galectin-3 and IL-17 Signaling. Tumor Angiogenesis and Modulators 2022. [DOI: 10.5772/intechopen.102893] [Reference Citation Analysis]
6 De Beck L, Awad RM, Basso V, Casares N, De Ridder K, De Vlaeminck Y, Gnata A, Goyvaerts C, Lecocq Q, San José-Enériz E, Verhulst S, Maes K, Vanderkerken K, Agirre X, Prosper F, Lasarte JJ, Mondino A, Breckpot K. Inhibiting Histone and DNA Methylation Improves Cancer Vaccination in an Experimental Model of Melanoma. Front Immunol 2022;13:799636. [PMID: 35634329 DOI: 10.3389/fimmu.2022.799636] [Reference Citation Analysis]
7 de Assis LVM, Lacerda JT, Moraes MN, Domínguez-Amorocho OA, Kinker GS, Mendes D, Silva MM, Menck CFM, Câmara NOS, Castrucci AML. Melanopsin (Opn4) is an oncogene in cutaneous melanoma. Commun Biol 2022;5:461. [PMID: 35562405 DOI: 10.1038/s42003-022-03425-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Morris RM, Mortimer TO, O'Neill KL. Cytokines: Can Cancer Get the Message? Cancers (Basel) 2022;14:2178. [PMID: 35565306 DOI: 10.3390/cancers14092178] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Ma VT, Lao CD, Fecher LA, Schiopu E. Successful use of secukinumab in two melanoma patients with immune checkpoint inhibitor-induced inflammatory arthropathy. Immunotherapy 2022. [PMID: 35416067 DOI: 10.2217/imt-2021-0274] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
10 Kortekaas Krohn I, Aerts JL, Breckpot K, Goyvaerts C, Knol E, Van Wijk F, Gutermuth J. T-cell subsets in the skin and their role in inflammatory skin disorders. Allergy 2022;77:827-42. [PMID: 34559894 DOI: 10.1111/all.15104] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
11 Tosi A, Nardinocchi L, Carbone ML, Capriotti L, Pagani E, Mastroeni S, Fortes C, Scopelliti F, Cattani C, Passarelli F, Rosato A, D'Atri S, Failla CM, Cavani A. Reduced Interleukin-17-Expressing Cells in Cutaneous Melanoma. Biomedicines 2021;9:1930. [PMID: 34944746 DOI: 10.3390/biomedicines9121930] [Reference Citation Analysis]
12 Geum S, Yoo J, Park H, Shin S. A Case of Metastatic Sinonasal Mucosal Melanoma Treated with Immunotherapy. J Clin Otolaryngol Head Neck Surg 2021;32:265-269. [DOI: 10.35420/jcohns.2021.32.3.265] [Reference Citation Analysis]
13 Varrone F, Mandrich L, Caputo E. Melanoma Immunotherapy and Precision Medicine in the Era of Tumor Micro-Tissue Engineering: Where Are We Now and Where Are We Going? Cancers (Basel) 2021;13:5788. [PMID: 34830940 DOI: 10.3390/cancers13225788] [Reference Citation Analysis]
14 Marques HS, de Brito BB, da Silva FAF, Santos MLC, de Souza JCB, Correia TML, Lopes LW, Neres NSM, Dórea RSDM, Dantas ACS, Morbeck LLB, Lima IS, de Almeida AA, Dias MRJ, de Melo FF. Relationship between Th17 immune response and cancer. World J Clin Oncol 2021; 12(10): 845-867 [PMID: 34733609 DOI: 10.5306/wjco.v12.i10.845] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
15 Nicola S, Ridolfi I, Rolla G, Filosso P, Giobbe R, Boita M, Culla B, Bucca C, Solidoro P, Brussino L. IL-17 Promotes Nitric Oxide Production in Non-Small-Cell Lung Cancer. J Clin Med 2021;10:4572. [PMID: 34640589 DOI: 10.3390/jcm10194572] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
16 Qiu Y, Su M, Liu L, Tang Y, Pan Y, Sun J. Clinical Application of Cytokines in Cancer Immunotherapy. Drug Des Devel Ther 2021;15:2269-87. [PMID: 34079226 DOI: 10.2147/DDDT.S308578] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 15.0] [Reference Citation Analysis]
17 Roy D, Bose S, Pati S, Guin A, Banerjee K, Saha S, Singhal AK, Chakraborty J, Sarkar DK, Sa G. GFI1/HDAC1-axis differentially regulates immunosuppressive CD73 in human tumor-associated FOXP3+ Th17 and inflammation-linked Th17 cells. Eur J Immunol 2021;51:1206-17. [PMID: 33555624 DOI: 10.1002/eji.202048892] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
18 Li T, Wu B, Yang T, Zhang L, Jin K. The outstanding antitumor capacity of CD4+ T helper lymphocytes. Biochim Biophys Acta Rev Cancer 2020;1874:188439. [PMID: 32980465 DOI: 10.1016/j.bbcan.2020.188439] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
19 Ralli M, Botticelli A, Visconti IC, Angeletti D, Fiore M, Marchetti P, Lambiase A, de Vincentiis M, Greco A. Immunotherapy in the Treatment of Metastatic Melanoma: Current Knowledge and Future Directions. J Immunol Res 2020;2020:9235638. [PMID: 32671117 DOI: 10.1155/2020/9235638] [Cited by in Crossref: 41] [Cited by in F6Publishing: 48] [Article Influence: 20.5] [Reference Citation Analysis]
20 Chen GG, Woo PYM, Ng SCP, Wong GKC, Chan DTM, van Hasselt CA, Tong MCF, Poon WS. Impact of metformin on immunological markers: Implication in its anti-tumor mechanism. Pharmacol Ther 2020;213:107585. [PMID: 32473961 DOI: 10.1016/j.pharmthera.2020.107585] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
21 Nistor GI, Dillman RO. Cytokine network analysis of immune responses before and after autologous dendritic cell and tumor cell vaccine immunotherapies in a randomized trial. J Transl Med 2020;18:176. [PMID: 32316978 DOI: 10.1186/s12967-020-02328-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
22 Tang Y, Chen M, Xie Q, Li L, Zhu L, Ma Q, Gao S. Construction and evaluation of hyaluronic acid-based copolymers as a targeted chemotherapy drug carrier for cancer therapy. Nanotechnology 2020;31:305702. [PMID: 32272454 DOI: 10.1088/1361-6528/ab884d] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
23 Borgers JSW, Tobin RP, Vorwald VM, Smith JM, Davis DM, Kimball AK, Clambey ET, Couts KL, McWilliams JA, Jordan KR, Torphy RJ, Schulick R, McCarter MD. High-Dimensional Analysis of Postsplenectomy Peripheral Immune Cell Changes. Immunohorizons 2020;4:82-92. [PMID: 32071067 DOI: 10.4049/immunohorizons.1900089] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
24 Briquez PS, Hauert S, de Titta A, Gray LT, Alpar AT, Swartz MA, Hubbell JA. Engineering Targeting Materials for Therapeutic Cancer Vaccines. Front Bioeng Biotechnol. 2020;8:19. [PMID: 32117911 DOI: 10.3389/fbioe.2020.00019] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
25 Slominski AT, Brożyna AA, Zmijewski MA, Janjetovic Z, Kim TK, Slominski RM, Tuckey RC, Mason RS, Jetten AM, Guroji P, Reichrath J, Elmets C, Athar M. The Role of Classical and Novel Forms of Vitamin D in the Pathogenesis and Progression of Nonmelanoma Skin Cancers. Adv Exp Med Biol 2020;1268:257-83. [PMID: 32918223 DOI: 10.1007/978-3-030-46227-7_13] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 12.0] [Reference Citation Analysis]
26 Logotheti S, Pützer BM. STAT3 and STAT5 Targeting for Simultaneous Management of Melanoma and Autoimmune Diseases. Cancers (Basel) 2019;11:E1448. [PMID: 31569642 DOI: 10.3390/cancers11101448] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]